Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease
A phase 3 trial of Epcoritamab, Prednisone, Rituximab in follicular lymphoma, run by Genmab, active and no longer recruiting.
Overview
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma is a phase 3 interventional study registered as NCT06191744 by Genmab, with 1095 participants enrolled, started 2024-02-05 and due to reach its primary completion in 2037-11. Interventions recorded: Epcoritamab, Prednisone, Rituximab, Lenalidomide, Doxorubicin. Conditions listed: Follicular Lymphoma (FL). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialTrial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
Shares Epcoritamab, Genmab, Prednisone, Vincristine.
- TrialSafety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
Shares Genmab, Prednisone, Vincristine, Lenalidomide.
- TrialStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease
Shares Epcoritamab, Genmab, Lenalidomide, Rituximab.
- TrialA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Th
Shares Epcoritamab, Genmab, Prednisone, Vincristine.
- TrialSafety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Shares Epcoritamab, Genmab, Prednisone, Vincristine.
- TrialA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neopl
Shares Epcoritamab, Genmab, Prednisone, Lenalidomide.
- TrialA Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
Shares Vincristine, Lenalidomide, Rituximab, Doxorubicin.
- TrialA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy
Shares Prednisone, Vincristine, Rituximab, Doxorubicin.